HETEROCYCLIC INHIBITORS OF BACTERIAL PEPTIDYL TRNA HYDROLASE AND USES THEREOF
    2.
    发明申请
    HETEROCYCLIC INHIBITORS OF BACTERIAL PEPTIDYL TRNA HYDROLASE AND USES THEREOF 审中-公开
    细菌肽类TRNA水解物的杂环抑制剂及其用途

    公开(公告)号:US20100069380A1

    公开(公告)日:2010-03-18

    申请号:US12441929

    申请日:2007-09-21

    摘要: Provided herein are compounds that modulate the activity of a bacterial peptidyl tRNA hydrolase, including compositions and dosage forms comprising the compounds. Further provided herein are methods for screening and identifying compounds that modulate the activity of a bacterial peptidyl tRNA hydrolase. In particular, provided herein are assays for the identification of compounds that inhibit or reduce the activity of a bacterial peptidyl tRNA hydrolase. The methods provided herein provide a simple, sensitive assay for high-throughput screening of libraries of compounds to identify pharmaceutical leads useful for preventing, treating, and managing a bacterial infection or one or more symptoms thereof. Further provided herein are methods for preventing or inhibiting bacterial proliferation as well as methods for preventing, treating, and/or managing a bacterial infection using such compounds and compositions.

    摘要翻译: 本文提供调节细菌肽基tRNA水解酶的活性的化合物,包括组合物和包含该化合物的剂型。 本文还提供了筛选和鉴定调节细菌肽基tRNA水解酶活性的化合物的方法。 特别地,本文提供了用于鉴定抑制或降低细菌肽基tRNA水解酶的活性的化合物的测定法。 本文提供的方法提供了一种用于高通量筛选化合物文库的简单敏感测定,以鉴定可用于预防,治疗和管理细菌感染或其一种或多种症状的药物引线。 本文还提供了用于预防或抑制细菌增殖的方法以及使用这些化合物和组合物预防,治疗和/或控制细菌感染的方法。

    NOVEL C-ARYL ANSA SGLT2 INHIBITORS
    6.
    发明申请
    NOVEL C-ARYL ANSA SGLT2 INHIBITORS 有权
    新型C-ARYL ANSA SGLT2抑制剂

    公开(公告)号:US20140213642A1

    公开(公告)日:2014-07-31

    申请号:US14123793

    申请日:2012-06-14

    IPC分类号: C07D491/056

    CPC分类号: C07D491/056 C07D493/08

    摘要: Disclosed is a novel C-aryl ansa compound having an inhibitory activity against sodium-dependent glucose cotransporter 2 (SGLT2) being present in the intestine and kidney, and a pharmaceutical composition comprising the same as an active ingredient, which is useful for preventing or treating metabolic disorders, particularly diabetes. Also provided are a method for preparing the compound, and a method for preventing or treating metabolic disorders, particularly diabetes, by using the compound.

    摘要翻译: 公开了一种对肠和肾中存在的钠依赖性葡萄糖协同转运蛋白2(SGLT2)具有抑制活性的新型C-芳基硫化合物,以及包含其作为活性成分的药物组合物,其可用于预防或治疗 代谢紊乱,特别是糖尿病。 还提供了制备该化合物的方法,以及通过使用该化合物来预防或治疗代谢紊乱,特别是糖尿病的方法。